title: Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man.
abstract: One possible cause of pulmonary failure after trauma is the type of asanguinous fluid used for resuscitation, i.e., crystalloid or colloid. To investigate this issue, patients having a laparotomy for trauma randomly received either Ringer's lactate (RLS) alone or Ringer's lactate with albumin (ALB). Both groups received washed red cells. Test fluids and red cells were given before and during operation to restore vital signs and hematocrit to normal. Pulmonary function tests were performed for 5 days after operation. One hundred and forty-one cases were studied (84 RLS, 57 ALB). The volume of asanguinous resuscitation fluid infused was 5.37 +/- 3.38 liters (-x +/- SD) for RLS and 5.87 +/- 3.05 liters for ALB. ALB cases received 213 +/- 130 gm of albumin. Red cell transfusions were 1.5 +/- 2.9 units for RLS and 2.0 +/- 3.1 for ALB. Six patients died (three RLS, there ALB). Three RLS and six ALB patients received intermittent mandatory ventilation or continous positive air pressure after operation. Pulmonary function results were not significantly different between the two groups for any parameter on any day after operation. Results of a randomized trial in human subjects of resuscitation with crystalloid and colloid solutions for acute trauma requiring laparotomy did not reveal significant differences in (1) survival rate, (2) incidence of pulmonary failure, or (3) postoperative pulmonary function.
mesh_terms: D000328:Adult; D001798:Blood Proteins / Q000032:analysis; D003102:Colloids / Q000009:adverse effects*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral / Q000009:adverse effects*; D008297:Male; D011182:Postoperative Care; D011654:Pulmonary Edema / Q000209:etiology*; D012121:Respiration, Artificial; D012128:Respiratory Distress Syndrome / Q000209:etiology*; D012129:Respiratory Function Tests; D012151:Resuscitation / Q000009:adverse effects; D012709:Serum Albumin / Q000627:therapeutic use; D012996:Solutions / Q000009:adverse effects*; D014947:Wounds and Injuries / Q000150:complications*
chemical_list: D001798:Blood Proteins; D003102:Colloids; D012709:Serum Albumin; D012996:Solutions